INTS - Intensity Tx P/S multiplikatori

intensitytherapeutics.com (INTS) tovar belgisi

Inertia platformasi patentlar bilan himoyalangan protokollar va barqaror talab hisobiga yuqori marjalarni ta'minlaydi. GURU.Markets tomonidan taqdim etilgan ushbu grafik narx/savdo ko'paytirgichi orqali daromadning bozor qiymatini aks ettiradi, belgisi esa joriy holatni ko'rsatadi. Klinik sinovlar davomida global izolyatsiya xatarlari mavjud bo'lishiga qaramay, AQSh huquqiy bazasida faoliyat yuritish Intensity Therapeutics (INTS) uchun dori vositalarini ishlab chiqish xavfsizligini ta'minlaydi.

INTS (Intensity Therapeutics) Narxning daromadga nisbati tarixi 04.07.2022dan 13.11.2026gacha

Intensity Therapeutics (INTS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:Intensity Therapeutics Inc, INTS
Intensity Tx ishlab chiqargan mahsulot

Intensity Therapeutics ulkan savdo salohiyatiga ega bo'lgan qattiq o'smalar uchun immunoterapiya segmentida faoliyat yuritadi. Ushbu ko'rsatkich biznesning bozor qiymatini uning haqiqiy daromadi bilan bog'lab, kelajakdagi o'sish uchun qo'shimcha qiymatni o'lchaydi. Kompaniyaning dinamik P/S ko'rsatkichini tahlil qilish baholashning joriy savdolarga nisbatan qanchalik shishirilganligini baholash imkonini beradi. Bu yerdagi yuqori koeffitsient investorlarning kelgusi klinik sinovlarning tijorat muvaffaqiyatiga bo'lgan ishonchini aks ettiradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati immunitybio.com IBRX|Immunocore - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Janux Therapeutics Inc JANX|RCUS - Narxning daromadga nisbati|ZYME (Zymeworks Biopharmaceuticals) - Kapitalizatsiya va daromad nisbati|Tango Therapeutics (TNGX) - Narxning daromadga nisbati|Sotuvga nisbatan narx iovance.com (IOVA)|Kapitalizatsiyaning daromadga nisbati IMTX|XNCR - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati CMPX (Compass Bio)|Kapitalizatsiyaning sotish hajmiga nisbati REPL|P/S multiplikatori LYEL (Lyell Immunopharma)|Bozor kapitallashuvining daromadga nisbati IPHA|Pyxis - P/S multiplikatori|Sotuvga nisbatan narx Compugen Ltd.|IO Biotech Corp (IOBT) - Narxning daromadga nisbati|Sutro Biopharma, Inc - Bozor kapitallashuvining daromadga nisbati|INKT (MiNK Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Werewolf|Narxning daromadga nisbati Immix Biopharma, Inc. (IMMX)|ALXO: Narxning sotuvga nisbati|Cue Biopharma, Inc. - Kapitalizatsiyaning daromadga nisbati|PDS Biotech (PDSB) - Sotuvga nisbatan narx|Sonnet BioTherapeutics Holdings Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti MAIABiotech.com MAIA|Liminatus Pharma LLC (LIMN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati LVTX|Kapitalizatsiyaning daromadga nisbati NXTC|LPTX (Leap Tx) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori SNSE|TOVX - Sotuvga nisbatan narx|Narxning daromadga nisbati Gritstone bio GRTS|KA: Kapitalizatsiya va daromad nisbati|NEXI - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Turnstone Biologics TSBX|VCNX: P/S multiplikatori|HARP - Narx/daromad koeffitsiyenti